Jean Torrisi

1.4k total citations
11 papers, 307 citations indexed

About

Jean Torrisi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jean Torrisi has authored 11 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Jean Torrisi's work include Ovarian cancer diagnosis and treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and MRI in cancer diagnosis (2 papers). Jean Torrisi is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and MRI in cancer diagnosis (2 papers). Jean Torrisi collaborates with scholars based in United States, Spain and France. Jean Torrisi's co-authors include George J. Bosl, Marc J. Gollub, Michelle S. Ginsberg, Hedvig Hricak, Lawrence H. Schwartz, David M. Hyman, Alexia Iasonos, Rachel N. Grisham, Carol Aghajanian and Roisin E. O’Cearbhaill and has published in prestigious journals such as Blood, Cancer and Radiology.

In The Last Decade

Jean Torrisi

11 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Torrisi United States 7 122 91 72 67 51 11 307
Amy Guppy United Kingdom 6 105 0.9× 38 0.4× 80 1.1× 67 1.0× 112 2.2× 10 298
Hayriye Tatlı Doğan Türkiye 11 107 0.9× 81 0.9× 101 1.4× 82 1.2× 19 0.4× 41 338
Anna Castiglione Italy 12 65 0.5× 94 1.0× 63 0.9× 76 1.1× 29 0.6× 19 366
Emir Charles Roach Türkiye 10 83 0.7× 164 1.8× 58 0.8× 86 1.3× 11 0.2× 17 364
Francesca Colonese Italy 10 171 1.4× 85 0.9× 64 0.9× 34 0.5× 92 1.8× 24 367
Gilad Gitstein Israel 8 117 1.0× 187 2.1× 33 0.5× 77 1.1× 25 0.5× 14 345
Bok Ai Choo Singapore 12 98 0.8× 144 1.6× 55 0.8× 160 2.4× 17 0.3× 29 364
Arzu Oğuz Türkiye 9 205 1.7× 60 0.7× 39 0.5× 53 0.8× 14 0.3× 36 310
Raj P. Pal United Kingdom 10 129 1.1× 177 1.9× 147 2.0× 79 1.2× 41 0.8× 21 420
Dalyong Kim South Korea 9 92 0.8× 65 0.7× 55 0.8× 102 1.5× 27 0.5× 27 304

Countries citing papers authored by Jean Torrisi

Since Specialization
Citations

This map shows the geographic impact of Jean Torrisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Torrisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Torrisi more than expected).

Fields of papers citing papers by Jean Torrisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Torrisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Torrisi. The network helps show where Jean Torrisi may publish in the future.

Co-authorship network of co-authors of Jean Torrisi

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Torrisi. A scholar is included among the top collaborators of Jean Torrisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Torrisi. Jean Torrisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Andrieu, Pamela Causa, Ines Nikolovski, Krishna Juluru, et al.. (2023). Synoptic Reporting for Pretreatment CT Examination in Patients With Advanced Ovarian Cancer: Impact on Documentation of Disease Sites and Physician Satisfaction. American Journal of Roentgenology. 221(6). 760–772. 3 indexed citations
2.
Wu, Jennifer, Michael Offin, Cecilia Lezcano, et al.. (2021). Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers. Investigational New Drugs. 39(3). 785–795. 21 indexed citations
5.
Zamarin, Dmitriy, Qin Zhou, Alexia Iasonos, et al.. (2020). Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial. Journal for ImmunoTherapy of Cancer. 8(1). e000829–e000829. 42 indexed citations
6.
Schram, Alison M., Eileen M. O’Reilly, Romel Somwar, et al.. (2019). Abstract PR02: Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers. Molecular Cancer Therapeutics. 18(12_Supplement). PR02–PR02. 24 indexed citations
7.
Rubinstein, Maria M., David M. Hyman, Helen Won, et al.. (2019). Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway. Cancer. 126(6). 1274–1282. 49 indexed citations
9.
Torrisi, Jean, Lawrence H. Schwartz, Marc J. Gollub, et al.. (2010). CT Findings of Chemotherapy-induced Toxicity: What Radiologists Need to Know about the Clinical and Radiologic Manifestations of Chemotherapy Toxicity. Radiology. 258(1). 41–56. 130 indexed citations
10.
Herskowitz, Michael M., et al.. (1998). Insignificance of small loculated pneumothoraces after core biopsies of peripheral lung lesions using the Temno biopsy needle.. American Journal of Roentgenology. 171(4). 1163–1163. 1 indexed citations
11.
Torrisi, Jean, et al.. (1995). Fibrovascular Polyps of the Esophagus. Journal of Computer Assisted Tomography. 19(1). 157–159. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026